The study team generated Prss8 -/- and Prss8 +/+ embryos by intercrossing heterozygous mice and assessed embryos at E9.5–E12.5. They reported embryonic lethality of Prss8 -/- embryos by E14.5 and focused analysis on hematopoietic tissues prior to death. Flow cytometry and imaging flow cytometry revealed a reduced frequency of both circulating primitive erythroblasts and EMP-derived definitive erythroblasts in yolk sac, placenta and fetal liver at E11.5–E12.5 in knockout embryos. The cohort showed fewer Ter119+, CD71+ erythroid cells in these compartments, consistent with a quantitative deficit in early erythroid populations. The authors assessed viability by heartbeat and morphology and used standard gating strategies for erythroid subsets; the source details the antibody panels and acquisition platforms used for these measurements.
Single-cell RNA sequencing of primitive erythroid cells from Prss8 -/- embryos identified distinct transcriptional differences compared with wild-type. Data indicated downregulation of fetal hemoglobin genes accompanied by an upregulation of multiple ribosomal genes in the primitive erythroid cluster, a pattern the investigators interpreted as defective terminal erythroid maturation. Bulk RNA-seq protocols and library preparations are described in the source, and sequencing data were deposited in GEO under accession numbers GSE275398 and GSE275399. The source did not report specific fold-changes or p-values in this summary; readers should consult the deposited datasets for numeric expression metrics and statistical details.
The authors noted that prostasin expression was absent in circulating erythroid cells, and they therefore proposed a cell-extrinsic mechanism by which prostasin regulates primitive erythropoiesis. Supporting that interpretation, transcriptomic alterations were observed in erythroid cells despite lack of prostasin expression within those cells themselves. The manuscript documents qRT-PCR primer sequences and western blot methods used to probe prostasin expression in embryonic tissues; nevertheless, the source did not claim a direct proteolytic target in erythroid progenitors. The investigators referenced prior literature on prostasin’s epithelial expression and ENaC activation, but the source did not present new in vivo biochemical confirmation of ENaC proteolysis in embryonic tissues.
Histology and whole-mount immunostaining revealed impaired yolk sac vascular remodeling in Prss8 -/- embryos. The study team observed reduced vessel branching and fewer junctions in the yolk sac vasculature of knockouts, based on CD31 and VE-cadherin staining. These vascular patterning defects were interpreted as likely contributors to impaired placental vascularization and to the subsequent embryonic demise. The source provides detailed fixation, staining and imaging protocols used to visualize vascular architecture, and it links the vascular phenotype to the observed deficits in erythropoiesis and circulation. The authors emphasize that altered yolk sac vascular networks would be expected to compromise oxygen and nutrient delivery during a developmental window that relies heavily on rapid erythroid expansion.
To assess progenitor function, investigators performed colony-forming unit (CFU) assays using single-cell suspensions from hematopoietic tissues plated in methylcellulose media. The source outlines cell preparation, plating densities and readout times; CFU enumeration was performed after seven to eight days in culture with automated microscopy. For fetal liver samples an additional plate was seeded to determine total CFU output per tissue. The manuscript also details downstream recovery and phenotyping of methylcellulose-grown cells by flow cytometry. The authors report alterations in erythroid progenitor frequencies in Prss8 -/- samples; the summary in the source does not enumerate absolute colony counts or statistical values here, so readers should review the deposited data for those specifics.
The report combines multiple complementary techniques—flow cytometry, imaging flow cytometry, histology, CFU assays, bulk and single-cell RNA sequencing—applied across relevant embryonic tissues (yolk sac, placenta, AGM, fetal liver). The RNA sequencing datasets are publicly available in GEO (GSE275398, GSE275399), facilitating independent inspection and reanalysis. The authors link a genetically documented association of a Prss8 SNP with human preeclampsia to their murine findings, but the source does not provide human embryonic or placental functional data as part of this report. The manuscript does not present in vivo biochemical proof that prostasin modulates ENaC in embryonic tissues; nor does the provided summary list detailed numerical results (fold-changes, p-values) for all transcriptomic comparisons—those figures and metrics must be consulted directly in the published paper and deposited datasets. Remaining specific questions include the precise molecular mediator(s) of the proposed cell-extrinsic effect on erythropoiesis, and whether interventions that rescue yolk sac vascular remodeling would restore erythroid maturation and embryonic viability—issues the source raises but does not resolve.